Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Cash & Current Investments (2016 - 2025)

Abeona Therapeutics (ABEO) has 15 years of Cash & Current Investments data on record, last reported at $207.5 million in Q3 2025.

  • For Q3 2025, Cash & Current Investments rose 88.53% year-over-year to $207.5 million; the TTM value through Sep 2025 reached $207.5 million, up 88.53%, while the annual FY2024 figure was $97.7 million, 85.91% up from the prior year.
  • Cash & Current Investments reached $207.5 million in Q3 2025 per ABEO's latest filing, down from $225.9 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $225.9 million in Q2 2025 and bottomed at $18.2 million in Q3 2022.
  • Average Cash & Current Investments over 5 years is $83.0 million, with a median of $62.3 million recorded in 2024.
  • Peak YoY movement for Cash & Current Investments: tumbled 74.41% in 2022, then skyrocketed 234.62% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $50.9 million in 2021, then grew by 3.09% to $52.5 million in 2022, then rose by 0.15% to $52.6 million in 2023, then soared by 85.91% to $97.7 million in 2024, then soared by 112.3% to $207.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $207.5 million in Q3 2025, $225.9 million in Q2 2025, and $152.7 million in Q1 2025.